Differential effects of TR ligands on hormone dissociation rates: Evidence for multiple ligand entry/exit pathways

Journal of Steroid Biochemistry and Molecular Biology

Volumn 117, Issue 4-5, 2009, Pages 125-131

  Cunha Lima, Suzana T ^a   Nguyen, Ngoc Ha ^b   Togashi, Marie ^c   Apriletti, James W ^b   Nguyen, Phuong ^b   Polikarpov, Igor ^d   Scanlan, Thomas S ^e   Baxter, John D ^f   Webb, Paul ^f  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRASILIA   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Dimerization; Kinetics; Ligand binding; Ligand dissociation; Selective modulator; Thyroid hormone receptor; Thyroxine; Triiodothyronine

Indexed keywords

HETERODIMER; LIGAND; LIOTHYRONINE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR BETA; THYROXINE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; DISSOCIATION CONSTANT; ENZYME KINETICS; HORMONE BINDING; HORMONE DETERMINATION; ISOTOPE LABELING; LIGAND BINDING; MOLECULAR DYNAMICS; NONHUMAN; SIGNAL TRANSDUCTION; THYROID HORMONE RELEASE;

DIMERIZATION; KINETICS; LIGANDS; RECEPTORS, THYROID HORMONE; THYROID HORMONES;

EID: 70350526968     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.08.003     Document Type: Article

References (29)

1. Laudet V., and Gronemeyer H. The Nuclear Receptor Facts Book. Factsbook Series. 1st ed. (2002), Academic Press, London
2. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 3 (2001) 1097-1142
3. Baxter J.D., and Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat. Rev. Drug Discov. 8 4 (2009) 308-320
4. Webb P., et al. Design of thyroid hormone receptor antagonists from first principles. J. Steroid Biochem. Mol. Biol. 83 1-5 (2002) 59-73
5. Nettles K.W., and Greene G.L. Ligand control of coregulator recruitment to nuclear receptors. Annu. Rev. Physiol. 67 (2005) 309-333
6. Togashi M., et al. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. J. Steroid Biochem. Mol. Biol. 93 2-5 (2005) 127-137
7. Glass C.K., and Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14 2 (2000) 121-141
8. Wagner R.L., et al. Hormone selectivity in thyroid hormone receptors. Mol. Endocrinol. 15 3 (2001) 398-410
9. Sandler B., et al. Thyroxine-thyroid hormone receptor interactions. J. Biol. Chem. 279 53 (2004) 55801-55808
10. Borngraeber S., et al. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proc. Natl. Acad. Sci. U.S.A. 100 26 (2003) 15358-15363
11. Martinez L., et al. Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors. Biophys. J. 89 3 (2005) 2011-2023
12. Martinez L., et al. Molecular dynamics simulations of ligand dissociation from thyroid hormone receptors: evidence of the likeliest escape pathway and its implications for the design of novel ligands. J. Med. Chem. 49 1 (2006) 23-26
13. Wagner R.L., et al. A structural role for hormone in the thyroid hormone receptor. Nature 378 6558 (1995) 690-697
14. Huber B.R., et al. Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domain. Mol. Endocrinol. 17 1 (2003) 107-116
15. Huber B.R., et al. Two resistance to thyroid hormone mutants with impaired hormone binding. Mol. Endocrinol. 17 4 (2003) 643-652
16. Carlson K.E., et al. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. Biochemistry 36 48 (1997) 14897-14905
17. Gee A.C., et al. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol. Endocrinol. 13 11 (1999) 1912-1923
18. Jeyakumar M., et al. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor. Biochemistry 47 28 (2008) 7465-7476
19. Togashi M., et al. Rearrangements in thyroid hormone receptor charge clusters that stabilize bound 3,5′,5-triiodo-l-thyronine and inhibit homodimer formation. J. Biol. Chem. 280 27 (2005) 25665-25673
20. Suthers M.B., Pressley L.A., and Funder J.W. Glucocorticoid receptors: evidence for a second, non-glucocorticoid binding site. Endocrinology 99 1 (1976) 260-269
21. Wang Y., et al. A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta. Proc. Natl. Acad. Sci. U.S.A. 103 26 (2006) 9908-9911
22. Ambrosio A.L., et al. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 282 25 (2007) 18625-18633
23. Estebanez-Perpina E., et al. Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor. Mol. Endocrinol. 21 12 (2007) 2919-2928
24. Estebanez-Perpina E., et al. A surface on the androgen receptor that allosterically regulates coactivator binding. Proc. Natl. Acad. Sci. U.S.A. 104 41 (2007) 16074-16079
25. Nguyen N.H., et al. Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonists. J. Am. Chem. Soc. 127 13 (2005) 4599-4608
26. Nguyen N.H., et al. Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment. J. Med. Chem. 45 15 (2002) 3310-3320
27. Schueler P.A., et al. Binding of 3,5,3′-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the alpha- and beta-forms for the acetic acid analog and failure of the human testis and kidney alpha-2 products to bind T3. Mol. Endocrinol. 4 2 (1990) 227-234
28. Ribeiro R.C., et al. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor. J. Biol. Chem. 276 18 (2001) 14987-14995
29. Sonoda M.T., et al. Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations. Mol. Endocrinol. 22 7 (2008) 1565-1578